Public Profile

Helicos BioSciences Corporation

Helicos BioSciences Corporation, a pioneering entity in the biotechnology sector, is headquartered in the United States. Founded in 2006, the company has made significant strides in the field of genomics, particularly with its innovative single-molecule sequencing technology. This unique approach allows for high-throughput, accurate DNA sequencing, setting Helicos apart from traditional methods. With a focus on research and development, Helicos BioSciences serves a diverse clientele, including academic institutions and pharmaceutical companies, primarily in North America and Europe. The company has achieved notable milestones, including the launch of its Helicos Genetic Analysis System, which has garnered attention for its ability to deliver rapid and precise genomic data. As a leader in the sequencing industry, Helicos continues to push the boundaries of genetic research, contributing to advancements in personalised medicine and genomics.

DitchCarbon Score

How does Helicos BioSciences Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

18

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

22

Industry Benchmark

Helicos BioSciences Corporation's score of 18 is lower than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.

35%

Helicos BioSciences Corporation's reported carbon emissions

Helicos BioSciences Corporation, headquartered in the US, currently does not have any publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their climate commitments or progress in reducing carbon footprints. The absence of documented initiatives suggests that Helicos may not have established formal climate pledges or reduction strategies at this time. As the industry increasingly prioritises sustainability, it will be important for Helicos to consider developing measurable climate commitments to align with global efforts in reducing greenhouse gas emissions.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Helicos BioSciences Corporation's primary industry is Medical, precision and optical instruments, watches and clocks (33), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Helicos BioSciences Corporation is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Helicos BioSciences Corporation is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero

Was this information valuable to you?

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers